搜索临床试验以:实验:OTL-203
总计7391个结果
-
Beech Tree Labs, Inc.Norwich Clinical Research Associates Ltd.; Curavit Clinical Research完全的
-
Dana-Farber Cancer InstituteNational Institutes of Health (NIH); Genus Oncology, LLC撤销
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of Medicine主动,不招人
-
Center for Social Innovation, MassachusettsNational Institute of Mental Health (NIMH); New York State Psychiatric Institute; Research Foundation... 和其他合作者完全的
-
Suzhou Connect Biopharmaceuticals, Ltd.主动,不招人
-
Shenzhen NewDEL Biotech, Co., LtdShenzhen Innovation Center for Small Molecule Drug Discovery Co., Ltd.邀请报名
-
Nanjing Leads Biolabs Co.,LtdHenan Cancer Hospital; Hunan Cancer Hospital; Shandong Cancer Hospital and Institute完全的
-
Orion Corporation, Orion PharmaEndo Pharmaceuticals完全的
-
National Cancer Institute (NCI)主动,不招人复发性 B 型急性淋巴细胞白血病 | 难治性 B 型急性淋巴细胞白血病 | 复发性混合表型急性白血病 | 难治性混合表型急性白血病美国
-
Beech Tree Labs, Inc.Norwich Clinical Research Associates Ltd.; Hill Top Research完全的
-
Nantes University Hospital终止
-
National Cancer Institute (NCI)主动,不招人不可切除的皮肤黑色素瘤 | 不可切除的黑色素瘤 | 临床 III 期皮肤黑色素瘤 AJCC v8 | 未知原发性黑色素瘤 | 粘膜黑色素瘤 | 临床 IV 期皮肤黑色素瘤 AJCC v8美国
-
Centre hospitalier de l'Université de Montréal...完全的
-
National Cancer Institute (NCI)NRG Oncology主动,不招人
-
Vascular Biogenics Ltd. operating as VBL Therapeutics完全的
-
National Cancer Institute (NCI)尚未招聘骨髓增生异常综合症 | 复发性急性髓性白血病 | 难治性急性髓性白血病 | 难治性慢性粒单核细胞白血病 | 难治性高危骨髓增生异常综合征
-
National Cancer Institute (NCI)主动,不招人
-
Shenzhen Geno-Immune Medical InstituteShenzhen Children's Hospital; Shenzhen Hospital of Southern Medical University未知